AB132. Neonatal diabetes in Wolcott-Rallison syndrome: a case report
Part 4: Oral/poster

AB132. Neonatal diabetes in Wolcott-Rallison syndrome: a case report

Ngoc Thi Bich Can1, Dung Chi Vu1, Sarah Flanagan2, Sian Ellard2

1Department of Endocrinology, Metabolism and Genetics, National Hospital of Pediatrics, Hanoi, Vietnam; 2Royal Denvon and Exter NHS Healthcare Trust, Exeter, UK


Background: Wolcott-Rallison syndrome (WRS) is a rare autosomal recessive disorder characterized by the association of permanent neonatal or early-infancy insulin-dependent diabetes, multiple epiphyseal dysplasia and growth retardation, and other variable multisystem clinical manifestations.

Objective: To describe clinical characteristics and genetic finding in the first Vietnamese patient with EIF2AK3 mutation.

Methods: Clinical features, biochemical finding, mutation analysis and management in a 64-day-old girl was study. Based on analysis of a 64-day-old girl’s clinical symptoms associated with biochemical examination, the diagnosis of WRS was therefore made. Genomic DNAs were extracted from peripheral blood leukocytes from the patient and her parents with their informed consent for genetic studies. The coding and flanking intronic regions of the EIFAK3 gene was analysed by sequencing.

Results and conclusions: The patient had gestation age of 41 weeks, birth weight of 3,200 g, and onset of the disease at 64 days of age. She was admitted with the features of convulsion, anemia, jaundice, diabetic ketoacidosis with pH of 7.27, HCO3 of 17.8 mmoL/L, BE of −8 mmoL/L, blood glucose 42.46 mmoL/L, HbA1C 6.5%, total bilirubin 59.2 µmoL/L, direct bilirubin 29.7 µmoL/L, AST 3,742.2 U/L, ALT 1,927 U/L. PCR of CMV, EBV, HAV were negative. Abdominal ultrasound did not find any sign of cholestasis. Sequencing analysis of patient’s EIF2AK3 gene has identified a homozygous missense mutation, p.R632W. The parents are carriers of heterozygous EIF2AK3 missense mutation, p.R632W. Now she is 3 years and 3 months old, she has normal development, good blood glucose control with the insulin dose of 1.0 UI/kg/day, no jaundice, HbA1c 5.8% (normal range, 4-6%), AST 30.43 UI/L, ALT 17.09 UI/L, not yet skeletal symtoms. Combining mutation screening of EIF2AK3 gene with clinical manifestations and effective examination may provide a reliable diagnostic method for patients.

Keywords: Wolcott-Rallison syndrome (WRS)


Cite this abstract as: Can NT, Vu DC, Flanagan S, Ellard S. Neonatal diabetes in Wolcott-Rallison syndrome: a case report. Ann Transl Med 2015;3(S2):AB132. doi: 10.3978/j.issn.2305-5839.2015.AB132

Download Citation